COVID-19 Vaccination: Prepare to Engage
Does COVID-19 Make a Better Case for Vaccines?
In consideration of the idea that the pandemic may lead to greater knowledge and adoption of preventive health measures.
What Should Be Achieved in Phase 3 COVID-19 Vaccine Trials?
Numerous candidates are in late-stage assessment. An expert shares what the diverse agents should show before being considered for regulation.
FDA Requires Lengthier COVID-19 Vaccine Safety Data for any Applications
The new guidance bucks against the White House's campaign message of an available prophylaxis by the election.
What to Make of the AstraZeneca COVID-19 Vaccine Trial Stalls
Perspective on the ongoing independent safety reviews for one of the more promising vaccine candidates.
Double Digit Decline in Infectious Disease Research During Coronavirus Pandemic
Incredible resources and effort have been put into the COVID-19 response, but other infectious disease priorities have also been displaced.
Patrick Howie, CEO of a firm which aggregates clinical analysis and data, explains.
Does Political Instability Lower Trust in Vaccines?
A new study in The Lancet maps trends in vaccine confidence around the world.
New Treatment Guidelines for Antibiotic Resistant Infections | IDSA Update
New guidance from the Infectious Diseases Society of America offers timely practice advice for the clinical treatment of three of the most common drug-resistant pathogens.
Intraseasonal Influenza Vaccine Effectiveness Waning: Threading the Needle for Immunity
Evidence is accumulating that influenza vaccination protection wanes over the course of a single influenza season, with significant implications for public health.
Introduction to Testing for Antibiotic Resistance
Robert H. Christenson, PhD, describes the threat of AMR and the role of relevant diagnostics in clinical settings.
Impractical Strategies for COVID-19
From immunity building to plasma research, a look at some lesser efficient practices adopted or proposed during the pandemic.
Examining Real-World Evidence for Oritavancin Use in Gram-Positive Infections
The challenges of making formulary and clinical decisions based on regulatory studies are significant and the need for real-world clinical experience is increasingly important.
What Makes Vaccines Safe?
A look at the processes and clinical practices at place to assure candidate safety during the COVID-19 vaccine race.
What COVID-19 Shares with SARS, Influenza, HIV
David Ho, MD, likens and contrasts the pandemic to 3 other viral outbreaks and their respective responses.
FDA Clears Favipiravir for COVID-19 Facility Outbreak Prevention Study
The clearance for the phase 2 preventive trial will seek the oral antiviral's benefit in elderly care facilities.
The 4 Ways the United States Failed in COVID-19 Response
David Ho, MD, shares insight into the public and scientific health shortcomings which burdened the nation back in March.
Vaccine Experts Sound Off On Current COVID-19 Developments
A look at the history of vaccines, our society's current standing in public health and vaccine preparedness, and what may come in the near future.
Does Data Improve Vaccine Adherence?
What role does new research play in combating public vaccination concerns?
How Are Vaccines Deemed Safe?
A discussion on the process by which the FDA regulates vaccine candidates at a time when COVID-19 candidates are progressing.
Can We Fight Coronavirus Without a Vaccine? Explaining Monoclonal Antibody Research
What happens if we don't get a COVID-19 vaccine? Patrick Soon-Shiong, MD, describes another potential route for research efforts, which could also supplement vaccine development.
Benefits of Routine Childhood Vaccination Versus Risk of Coronavirus Infection
A benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
A World Without Antibiotics? Why Patients Should Care About Resistance
Dr. Pol Vandenbroucke describes the individual and collective risks associated with rising antibiotic resistance.
The Stakes of Antibiotic Stewardship
Dr. Pol Vandenbroucke talks about what makes antibiotic stewardship so important to clinicians and researchers.
Building Global Antibiotic Resistance Monitoring Capacities
Dr. Pol Vandenbroucke explains how the development of health and civil society infrastructure around the world helps to slow antimicrobial resistance.
Loss of Life From Antibiotic Resistance May Surpass Cancer By 2050
Dr. Pol Vandenbroucke describes the alarming global threat of antimicrobial resistance.
IV-to-Oral Antibiotic Courses May Reduce Invasive Infection Readmissions During Opioid Epidemic
Providing oral antibiotics to people who inject drugs with infections may reduce hospital readmissions.
Vertical Antimicrobial Stewardship Can Take Programs to New Heights
Expansion of antimicrobial stewardship strategies to include vertical methods represents an opportunity for programs, both new and established, to further optimize antimicrobial use.
Dr. Patrick Soon-Shiong: Goals of Operation Warp Speed
Patrick Soon-Shiong, MD, describes goals and expectations for the accelerated coronavirus vaccine program Operation Warp Speed.
HIV Cure Research Has Slowed, But Still Progresses
The COVID-19 pandemic has put the brakes on HIV cure research, but investigators report recent progress and promising pathways nonetheless.
Evaluating Favipiravir For COVID 19
Armand Balboni, MD, PHD, CEO of Appili Therapeutics, discusses work with favipiravir on a new front for the drug — the global search for COVID-19 treatment and prevention therapies.
2 Clarke Drive Cranbury, NJ 08512